GASTROESOPHAGEAL CANCER

This study aimed to see if approved immunotherapy drugs (nivolumab with or without ipilimumab) could help people with early-stage colorectal or gastroesophageal cancer delay or avoid major surgery to remove their tumors. The goal was an 'organ preservation' strategy, using the dr…

This early-stage trial is testing the safety and finding the right dose of a two-drug combination (naptumomab estafenatox and durvalumab) for people with advanced or metastatic solid tumors. It will enroll about 120 adults with one of many eligible cancer types, including breast,…

This study is testing if giving targeted, high-dose radiation to cancer spots before starting immunotherapy drugs makes the drugs work better for people with advanced stomach or esophageal cancer. It's a small, early-stage safety trial for patients whose cancer has spread but is …

This study is testing whether an experimental drug called sacituzumab tirumotecan helps people with advanced stomach or esophageal cancer live longer than the current standard treatments. It is for people whose cancer has continued to grow despite trying at least two prior drug t…

This study is testing whether a remote support program that provides nutrition guidance is practical and helpful for people with esophageal or stomach cancer. The program uses a mobile app to help patients track their food while they are going through chemotherapy and radiation. …

This study aims to find early signs of heart damage in cancer patients receiving radiation therapy to the chest. Researchers will use special heart scans and blood tests on 28 participants before, during, and after their radiation treatment. The goal is to learn how to identify p…

This study aimed to collect blood and tumor tissue samples from people with stomach or esophageal cancer. Researchers wanted to analyze these samples to understand why some cancers stop responding to immunotherapy drugs. The study was withdrawn before any participants were enroll…